Thermo Fisher Scientific Inc. (LON:0R0H)
590.54
+0.09 (0.02%)
At close: Nov 28, 2025
Thermo Fisher Scientific Employees
Thermo Fisher Scientific had 125,000 employees as of December 31, 2024. The number of employees increased by 3,000 or 2.46% compared to the previous year.
Employees
125,000
Change (1Y)
3,000
Growth (1Y)
2.46%
Revenue / Employee
260.91K GBP
Profits / Employee
39.19K GBP
Market Cap
167.69B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 125,000 | 3,000 | 2.46% |
| Dec 31, 2023 | 122,000 | -8,000 | -6.15% |
| Dec 31, 2022 | 130,000 | 0 | - |
| Dec 31, 2021 | 130,000 | 50,000 | 62.50% |
| Dec 31, 2020 | 80,000 | 5,000 | 6.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
Thermo Fisher Scientific News
- 4 days ago - Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes - Business Wire
- 8 days ago - Why Is Thermo Fisher (TMO) Up 0.2% Since Last Earnings Report? - Nasdaq
- 9 days ago - Thermo Fisher Scientific's Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer - Business Wire
- 9 days ago - TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner - Nasdaq
- 10 days ago - Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing* - Business Wire
- 11 days ago - Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs for Advanced Therapeutics to Help Accelerate Cell and Gene Therapy Development - Business Wire
- 11 days ago - Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' - Benzinga
- 12 days ago - Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH - CNBC